Omnicell (OMCL) Shares are Down -1.38%

Omnicell (OMCL) has risen sharply, recording gains of 4.72% in the past 4 weeks. However, the stock has corrected -1.38% in the past 1 week, providing a good buying opportunity on dips. On a relative basis, the stock has outperformed the S&P 500 by 4.32% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week.

Omnicell, Inc. is up 19.41% in the last 3-month period. Year-to-Date the stock performance stands at 19.18%. The stock has recorded a 20-day Moving Average of 0.62% and the 50-Day Moving Average is 3.9%.


Omnicell (NASDAQ:OMCL): During Fridays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $36.82 and $36.68 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $37.17. The buying momentum continued till the end and the stock did not give up its gains. It closed at $37.04, notching a gain of 0.11% for the day. The total traded volume was 108,545 . The stock had closed at $37.00 on the previous day.

Also, Equity Analysts at the FBR Capital maintains the rating on Omnicell (NASDAQ:OMCL). The brokerage firm has issued a Outperform rating on the shares. The Analysts at the ratings agency raises the price target from $40 per share to $41 per share. The rating by the firm was issued on July 29, 2016.

Omnicell, Inc. (Omnicell) is a provider of automation and business information solutions designed to enable healthcare systems to streamline the medication administration process and manage medical supplies for increased operational efficiency and enhanced patient safety. The Company has two operating segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment is organized around the design, manufacturing, selling and servicing of medication and supply dispensing systems, pharmacy inventory management systems, and related software. The Medication Adherence segment primarily includes the manufacturing and selling of consumable medication blister cards, packaging equipment and ancillary products and services. The Companys products include OmniRx, SinglePointe, AnywhereRN, OptiFlex MS, OptiFlex CL, AccuFlex, Autobond, AutoGen, and SureSeal, among others.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.